Certificate of Analysis

Tesamorelin 20 mg

PeakTrace CoA PT-COA-2026-0007 — tested 2026-09-10, issued 2026-09-16. The full document is below. Download the PDF, or check it directly with the laboratory.

The CoA, written out

Certificate of Analysis

PeakTrace

PT-COA-2026-0007 · version 2

Tesamorelin

20.02 mg

20 mg (declared)

Purity

99.49%

Minimum 98%

Within specification

Declared compound: Tesamorelin
Declared quantity: 20 mg
Sample ID: PT-S-2026-0004
Test date: 2026-09-10
Issue date: 2026-09-16

All reported parameters are within the stated specification. This applies to the sample analysed and to the scope described above only.

Declared values are supplied by the customer and are recorded separately from measured results.
Findings apply to the vial analysed and not to any other unit.
A purity percentage is a proportion of the material analysed. It does not establish sterility or suitability for use.
This document does not establish that other units are identical, nor that the material is sterile, effective or safe to use.

Verify this report directly with the laboratory: look up PT-COA-2026-0007 at www.peaktrace.ca/verify.

For laboratory research use only. Not for human or veterinary use. A Certificate of Analysis describes the vial analysed; it does not establish that other units are identical, sterile, or suitable for any use.